Compugen (CGEN) Current Deferred Revenue (2009 - 2026)
Compugen recorded quarterly Current Deferred Revenue of $11.6 million in Q1 2026, up 5.72% quarter-over-quarter from $11.0 million in Q4 2025.
Compugen's Current Deferred Revenue history runs 5 years deep, the most recent figure standing at $11.6 million for Q1 2026.
- In Q1 2026, Current Deferred Revenue changed N/A year-over-year to $11.6 million; the TTM figure through Mar 2026 stood at $11.6 million (changed N/A YoY), while the FY2025 annual figure was $11.0 million, up 13.89% from the prior year.
- Current Deferred Revenue came in at $11.6 million for Q1 2026 at Compugen, up from $11.0 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $11.6 million in Q1 2026 to a low of $9.6 million in Q4 2024.
- A 4-year average of $10.8 million and a median of $11.1 million in 2023 frame the typical range for Current Deferred Revenue.
- Across the five-year window, Current Deferred Revenue slipped 13.61% in 2024 and rose 13.89% in 2025, its largest moves.
- Compugen's Current Deferred Revenue stood at $11.1 million in 2023, then dropped by 13.61% to $9.6 million in 2024, then increased by 13.89% to $11.0 million in 2025, then climbed by 5.72% to $11.6 million in 2026.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $11.6 million, $11.0 million, and $9.6 million for Q1 2026, Q4 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.60 Mn |
| Dec 31, 2025 | 10.97 Mn |
| Sep 30, 2025 | 10.68 Mn |
| Jun 30, 2025 | 29.59 Mn |
| Mar 31, 2025 | 9.63 Mn |
| Dec 31, 2024 | 9.63 Mn |
| Sep 30, 2024 | 15.91 Mn |
| Jun 30, 2024 | 11.25 Mn |
| Mar 31, 2024 | 10.76 Mn |
| Dec 31, 2023 | 11.15 Mn |
| Sep 30, 2016 | 53,000.00 |
| Jun 30, 2016 | 123,000.00 |
| Mar 31, 2016 | 219,000.00 |
| Dec 31, 2015 | 312,000.00 |
| Sep 30, 2015 | 824,000.00 |
| Jun 30, 2015 | 1.05 Mn |
| Mar 31, 2015 | 1.28 Mn |
| Dec 31, 2014 | 1.79 Mn |
| Sep 30, 2014 | 2.02 Mn |
| Jun 30, 2014 | 3.12 Mn |
| Mar 31, 2014 | 797,000.00 |
| Dec 31, 2013 | 5.32 Mn |
| Sep 30, 2013 | 5.78 Mn |
| Sep 30, 2010 | 69,000.00 |
| Jun 30, 2010 | 69,000.00 |
| Mar 31, 2010 | 50,000.00 |
| Dec 31, 2009 | 113,000.00 |
| Sep 30, 2009 | 62,000.00 |
| Jun 30, 2009 | 62,000.00 |
| Mar 31, 2009 | 100,000.00 |